S. Loginova

Studying the Effectiveness of Ribavirin® in the Experimental Form of Severe Acute Respiratory Syndrome

V. A. Maksimov, S. Borisevich, S. Loginova, 2020, Antibiotics and Chemotherapy.

Development of monoclonal antibodies to highly pathogenic avian influenza H5N1 virus and their application to diagnostics, prophylaxis, and therapy.

D. Lvov, V. Bondarev, O. Masalova, 2011, Acta virologica.

[In vitro activity of human recombinant alpha-2b interferon against SARS-CoV-2 virus].

S. Loginova, S. Borisevich, S. Savenko, 2021, Voprosy virusologii.

A new mouse unilateral model of diffuse alveolar damage of the lung

I. Smirnov, A. Belogurov, D. V. Yashin, 2022, Inflammation Research.

Study of the Activity of Antiviral Drugs Against the Causative Agent of Chikungunya Fever in Cell Culture

R. V. Sakharov, S. Borisevich, S. Loginova, 2023, Antibiotics and Chemotherapy.

[Investigation of Therapeutic Efficacy of Triazavirin Against Experimental Forest-Spring Encephalitis on Albino Mice].

O. Chupakhin, V. Rusinov, S. Loginova, 2015, Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic].

Antiviral Activity of Kagocel® in vitro Against Virus SARS-CoV-2

S. Loginova, V. Shchukina, S. Savenko, 2020 .

Experimental evaluation of the activity of the product meflochine against coronavirus SАRS-CoV-2

V. Bykov, S. Loginova, K. Filin, 2020, Medicine of Extreme Situations.